OKYO Pharma Limited (NASDAQ:OKYO) traded at $1.10 at close of the session on current trade day and made an upward move of 2.82% on its previous day’s price.
Looking at the stock we see that its previous close was $1.07 and the beta (5Y monthly) reads -3.37 with the day’s price range being $1.0601 – $1.11. In terms of its 52-week price range, OKYO has a high of $1.90 and a low of $0.81. The company’s stock has gained about 8.42% over that past 30 days.
OKYO Pharma Limited has a market cap of $37.11 million and is expected to release its quarterly earnings report in March.
On the other hand, looking at the outlook for the OKYO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the OKYO Pharma Limited (OKYO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 1.68% off its SMA20 and 1.32% from its 50-day simple moving average. The RSI (14) is pointing at 51.36 while the volatility over the past week is 5.31% and jumps to 9.02% over the past one month. The beta value is -0.27, while the average true range (ATR) is currently pointing at 0.09.
Coming back to OKYO Pharma Limited (NASDAQ:OKYO), we note that the average 3-month trading volume was 129.32K, while that of the preceding 10-day period stands at 64850.0. Current shares outstanding are 33.94 million.
The insiders hold 27.57% of the company’s shares while institutions hold 3.03%. The data shows that short shares as of 2025-01-31, stood at 0.33 million at a short ratio of 1.11. This represents a 135.00 short interest in shares outstanding on 2025-01-31. Shares short rose in January from the previous month at 0.22 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -4.77% down in year-to-date price movement.
